FDA 510(k) · Masimo

K992238: MASIMO SET RADICAL PULSE OXIMETER, LNOP-ADT, LNOP-PDT, LNOP-NEO, LNOP-NEO PT, LNOP-DCI, PATIENT CABLE (PC04, PC08, PC12) (Masimo Corp.)

Masimo Corp. received FDA 510(k) K992238 for MASIMO SET RADICAL PULSE OXIMETER, LNOP-ADT, LNOP-PDT, LNOP-NEO, LNOP-NEO PT, LNOP-DCI, PATIENT CABLE (PC04, PC08, PC12), with a decision date of Oct 8, 1999 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K992238

FDA facts

Official fields for K992238
FDA numberK992238
Pathway510(k)
ApplicantMasimo Corp.
Device nameMASIMO SET RADICAL PULSE OXIMETER, LNOP-ADT, LNOP-PDT, LNOP-NEO, LNOP-NEO PT, LNOP-DCI, PATIENT CABLE (PC04, PC08, PC12)
Product codeDQA: Oximeter
Regulation (21 CFR)870.2700
Device classClass 2
Date receivedJul 2, 1999
Decision dateOct 8, 1999
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

We could not extract the indications for this record (no summary PDF was processed). Check the FDA record for its summary or statement.

Predicates parsed from FDA documents

No predicate numbers were parsed for this record. The FDA summary, if available, names the predicate.

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DQA is "Oximeter", class 2, 21 CFR 870.2700.

Our labels for filtering: claim SpO2 / pulse oximetry, sensor Finger PPG. These are heuristics, not FDA fields.